vs
Side-by-side financial comparison of BJs RESTAURANTS INC (BJRI) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $355.4M, roughly 1.4× BJs RESTAURANTS INC). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 3.6%, a 3.3% gap on every dollar of revenue. On growth, BJs RESTAURANTS INC posted the faster year-over-year revenue change (3.2% vs -1.7%). Over the past eight quarters, BJs RESTAURANTS INC's revenue compounded faster (2.6% CAGR vs -0.1%).
BJ's Restaurants Inc. operates a chain of casual dining restaurants across the United States. Its menu features signature deep-dish pizzas, craft beers, handcrafted cocktails, and a wide range of American comfort food. The brand primarily serves family groups, friend gatherings, and casual diners seeking affordable, high-quality meals in a relaxed, welcoming in-store environment.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
BJRI vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $355.4M | $493.8M |
| Net Profit | $12.6M | $33.7M |
| Gross Margin | 74.5% | — |
| Operating Margin | 3.1% | 9.9% |
| Net Margin | 3.6% | 6.8% |
| Revenue YoY | 3.2% | -1.7% |
| Net Profit YoY | -24.2% | 10.5% |
| EPS (diluted) | $0.58 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $355.4M | $493.8M | ||
| Q3 25 | $365.6M | $492.9M | ||
| Q2 25 | $348.0M | $468.8M | ||
| Q1 25 | — | $458.4M | ||
| Q4 24 | $325.7M | $502.4M | ||
| Q3 24 | $349.9M | $511.2M | ||
| Q2 24 | $337.3M | $504.3M | ||
| Q1 24 | — | $495.1M |
| Q4 25 | $12.6M | $33.7M | ||
| Q3 25 | $22.2M | $71.7M | ||
| Q2 25 | $13.5M | $39.3M | ||
| Q1 25 | — | $20.7M | ||
| Q4 24 | $-2.9M | $30.5M | ||
| Q3 24 | $17.2M | $19.4M | ||
| Q2 24 | $7.7M | $-153.0M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | 74.5% | — | ||
| Q3 25 | 75.2% | — | ||
| Q2 25 | 75.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 73.4% | — | ||
| Q3 24 | 74.3% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | 3.1% | 9.9% | ||
| Q3 25 | 5.8% | 13.8% | ||
| Q2 25 | 4.3% | 12.8% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | -0.8% | 7.8% | ||
| Q3 24 | 3.8% | 6.6% | ||
| Q2 24 | 2.4% | -31.3% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 3.6% | 6.8% | ||
| Q3 25 | 6.1% | 14.5% | ||
| Q2 25 | 3.9% | 8.4% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | -0.9% | 6.1% | ||
| Q3 24 | 4.9% | 3.8% | ||
| Q2 24 | 2.3% | -30.3% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | $0.58 | $0.40 | ||
| Q3 25 | $0.97 | $0.84 | ||
| Q2 25 | $0.58 | $0.46 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | $-0.13 | $0.37 | ||
| Q3 24 | $0.72 | $0.23 | ||
| Q2 24 | $0.32 | $-1.84 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.8M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $366.2M | $865.9M |
| Total Assets | $1.0B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.8M | $375.2M | ||
| Q3 25 | $26.0M | $340.1M | ||
| Q2 25 | $19.0M | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | $18.4M | $229.9M | ||
| Q3 24 | $16.2M | $103.8M | ||
| Q2 24 | $18.8M | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | $60.5M | $577.2M | ||
| Q2 25 | $85.5M | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | $66.5M | $597.1M | ||
| Q3 24 | $63.5M | — | ||
| Q2 24 | $58.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | $366.2M | $865.9M | ||
| Q3 25 | $386.6M | $890.7M | ||
| Q2 25 | $371.5M | $833.8M | ||
| Q1 25 | — | $789.2M | ||
| Q4 24 | $376.2M | $764.9M | ||
| Q3 24 | $386.5M | $732.5M | ||
| Q2 24 | $375.4M | $706.5M | ||
| Q1 24 | — | $856.2M |
| Q4 25 | $1.0B | $2.2B | ||
| Q3 25 | $1.0B | $2.2B | ||
| Q2 25 | $1.0B | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $1.0B | $2.2B | ||
| Q3 24 | $1.0B | $2.1B | ||
| Q2 24 | $1.0B | $2.0B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | 0.16× | 0.65× | ||
| Q2 25 | 0.23× | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 0.18× | 0.78× | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $114.1M | ||
| Q3 25 | $62.3M | $137.3M | ||
| Q2 25 | $4.6M | $137.2M | ||
| Q1 25 | — | $-117.5M | ||
| Q4 24 | $27.3M | $133.0M | ||
| Q3 24 | $20.2M | $91.8M | ||
| Q2 24 | $22.3M | $107.0M | ||
| Q1 24 | — | $-125.2M |
| Q4 25 | — | — | ||
| Q3 25 | $41.9M | — | ||
| Q2 25 | $-12.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $735.0K | — | ||
| Q2 24 | $448.0K | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | -3.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 6.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 2.80× | 1.91× | ||
| Q2 25 | 0.34× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 1.18× | 4.72× | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BJRI
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
